Your browser doesn't support javascript.
loading
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.
Lehtisalo, Minna; Tarkiainen, E Katriina; Neuvonen, Mikko; Holmberg, Mikko; Kiiski, Johanna I; Lapatto-Reiniluoto, Outi; Filppula, Anne M; Kurkela, Mika; Backman, Janne T; Niemi, Mikko.
Afiliação
  • Lehtisalo M; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Tarkiainen EK; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.
  • Neuvonen M; Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
  • Holmberg M; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Kiiski JI; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.
  • Lapatto-Reiniluoto O; Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
  • Filppula AM; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Kurkela M; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.
  • Backman JT; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Niemi M; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.
Clin Pharmacol Ther ; 115(1): 71-79, 2024 01.
Article em En | MEDLINE | ID: mdl-37786998
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Glucuronídeos Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Glucuronídeos Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article